MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.
Shaoxi NiuXin MaYu ZhangYen-Nien LiuXufeng ChenHuijie GongYuanxin YaoKan LiuXu ZhangPublished in: PloS one (2018)
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, which shows high aggressiveness and lacks biomarkers. RhoB acts as a tumor suppressor that inhibits the progression of ccRCC. In the present study, we examined the effects of oncogenic microRNAs, miR-19a and miR-19b, on RhoB expression in ccRCC cells. The results showed that both miR-19a and miR-19b could directly target the 3'untranslated region (3'UTR) of RhoB, resulting in the reduced expression of RhoB. With RT-PCR analysis, we detected the increased expression of miR-19a and miR-19b in ccRCC tissues compared to adjacent non-tumor renal tissues. These data also demonstrated an exclusive negative correlation between miR-19a/19b and RhoB expression in ccRCC specimens and cell lines. In addition, the knockdown of RhoB or overexpression of miR-19a and miR-19b in ccRCC cells could promote cell proliferation, migration and invasion. These data demonstrate the direct roles of miR-19a and miR-19b on the repression of RhoB and its consequences on tumorigenesis, cancer cell proliferation and invasiveness. These results suggest the potential clinical impact of miR-19a and miR-19b as molecular targets for ccRCC.
Keyphrases
- cell proliferation
- long non coding rna
- poor prognosis
- long noncoding rna
- cell cycle
- pi k akt
- gene expression
- renal cell carcinoma
- cell cycle arrest
- squamous cell carcinoma
- transcription factor
- machine learning
- drug delivery
- papillary thyroid
- electronic health record
- young adults
- oxidative stress
- risk assessment
- deep learning
- artificial intelligence
- single molecule